Abstract
Despite effective treatments and long-standing management guidelines, there are approximately 1400 hospital admissions for asthma weekly in the United Kingdom (UK), many of which could be avoided. In our previous research, a secondary analysis of the intervention (ARRISA) suggested an improvement in the management of at-risk asthma patients in primary care. ARRISA involved identifying individuals at risk of adverse asthma events, flagging their electronic health records, training practice staff to develop and implement practice-wide processes of care when alerted by the flag, plus motivational reminders. We now seek to determine the effectiveness and cost-effectiveness of ARRISA in reducing asthma-related crisis events. We are undertaking a pragmatic, two-arm, multicentre, cluster randomised controlled trial, plus health economic and process evaluation. We will randomise 270 primary care practices from throughout the UK covering over 10,000 registered patients with 'at-risk asthma' identified according to a validated algorithm. Staff in practices randomised to the intervention will complete two 45-min eLearning modules (an individually completed module giving background to ARRISA and a group-completed module to develop practice...Continue Reading
References
Dec 1, 1991·Thorax·R YoonA Bauman
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·A E TattersfieldA Ullman
Jan 14, 2004·BMJ : British Medical Journal·Chris GriffithsGene S Feder
May 6, 2004·Health Economics·Elisabeth FenwickAndrew Briggs
Jun 3, 2005·Health Technology Assessment : HTA·J R SmithI Harvey
Aug 2, 2005·Thorax·P M SturdyUNKNOWN National Asthma Campaign Mortality and Severe Morbidity Group
May 17, 2006·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Michael J NobleJennifer Windley
Aug 1, 2006·Thorax·T HaahtelaL A Laitinen
Jun 19, 2009·American Journal of Respiratory and Critical Care Medicine·Helen K ReddelUNKNOWN American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations
Aug 1, 2009·American Journal of Respiratory and Critical Care Medicine·Jacqueline GambleLiam G Heaney
Feb 2, 2010·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Hilary PinnockBronwen Wagstaff
Aug 2, 2011·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Stanley J SzeflerBradley E Chipps
Oct 18, 2011·Lancet·Gene FederDebbie Sharp
Feb 4, 2012·BMJ : British Medical Journal·Christopher C ButlerKerenza Hood
Feb 14, 2012·The Journal of Allergy and Clinical Immunology·Jasmina I IvanovaKimmie McLaurin
Feb 24, 2012·Lancet·Anthony J AveryAziz Sheikh
Jul 4, 2012·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Hilary PinnockDavid Price
Sep 4, 2012·Thorax·Jane Rebecca SmithAndrew M Wilson
Jan 15, 2013·Trials·Aileen GrantBruce Guthrie
Mar 21, 2015·BMJ : British Medical Journal·Graham F MooreJanis Baird
Jun 22, 2016·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Robert FleetcroftNicholas Steel
Aug 30, 2016·BMC Medicine·Mome MukherjeeAziz Sheikh
Mar 18, 2017·BMC Medicine·Hilary PinnockUNKNOWN PRISMS and RECURSIVE groups
Jul 15, 2018·Thorax·Ramyani P GuptaDavid P Strachan
Citations
Mar 7, 2020·Pediatric Pulmonology·Stanley J SzeflerWarren Lenney
Jun 20, 2020·NPJ Primary Care Respiratory Medicine·Monica J FletcherThys van der Molen
Jun 17, 2021·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Michael NobleAndrew M Wilson